IBM in Talks With Australia On Settlement Over Bungled Census 

International Business Machines Corp. is negotiating a settlement with Australia's government over a bungled effort to oversee the country's first online census, senior executives said Tuesday. (published 0227 GMT)

 
 
Kyushu Railway Shares Soar 20% Over IPO Price in Tokyo Debut 

Kyushu Railway Co. made its debut on the Tokyo Stock Exchange Tuesday as its shares climbed 20% against the initial public offering price in the first 15 minutes of trading. (published 0123 GMT)

 
 
GOME Electrical Appliances: Expects January-September Net Profit to Fall 70%-80% on Year 

GOME Electrical Appliances Holding Ltd., an electrical appliance retailer in China and Hong Kong, said late Monday it expects its net profit for the January-September period to fall 70%-80% from a year earlier, due to the implementation of a transformation plan to improve its retail strategy. (published 0149 GMT)

 
 
Mapletree Industrial Trust 2Q Distribution Per Unit 2.83 Singapore Cents 

Mapletree Industrial Trust Tuesday said its fiscal-second quarter distribution per unit rose 1.4%, helped mainly by a rise in rentals. (published 0117 GMT)

 
 
Belle International Interim Net Profit Down 20% on Year 

Shoe retailer Belle International Holdings Ltd. late Monday reported a 20% drop in its interim net profit, partly dragged down by weaker same store sales and increased cost of sale. (published 0113 GMT)

 
 
Quam Expects April-Sept Results to Worsen Significantly From Year Earlier 

Financial services company Quam Ltd. said late Monday it expects its April-September financial results to worsen significantly from a year earlier due to weak market sentiment. (published 0054 GMT)

 
 
CapitaLand Retail China Trust: 3Q Distribution Per Unit 2.36 Singapore Cents, Down 11% On Year 

CapitaLand Retail China Trust, a Singapore-based real estate investment trust, said Tuesday that its third-quarter distribution per unit dropped 11% from a year earlier to 2.36 Singapore cents, due to weaker net property income. (published 0045 GMT)

 
 
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment 

Merck & Co.'s immunotherapy cancer drug Keytruda received U.S. Food and Drug Administration approval as a first-line treatment for certain lung cancer patients. (published 0020 GMT)

 
 
 

(END) Dow Jones Newswires

October 24, 2016 23:15 ET (03:15 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.